Evidence map›Paper›PMID 35739098›Full record

ArticleLight, science & applications2022

Rapid species identification of pathogenic bacteria from a minute quantity exploiting three-dimensional quantitative phase imaging and artificial neural network.

Geon Kim, Daewoong Ahn, Minhee Kang, Jinho Park, DongHun Ryu, YoungJu Jo, Jinyeop Song, Jea Sung Ryu, Gunho Choi, Hyun Jung Chung and 7 more

Abstract read
In one paragraph

Article in Light, science & applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The Fires of Isengard Have Spread:Pathogens (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. How AI can help us beat AMR.npj antimicrobials and resistance · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. On the use of deep learning for phase recovery.Light, science & applications · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Geon KimDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Daewoong AhnTomocube Inc., Daejeon, 34109, Republic of Korea.
Minhee KangSmart Healthcare & Device Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
Jinho ParkDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
DongHun RyuDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
YoungJu JoDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.ORCID http://orcid.org/0000-0002-2364-7160
Jinyeop SongDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Jea Sung RyuGraduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Gunho ChoiTomocube Inc., Daejeon, 34109, Republic of Korea.
Hyun Jung ChungGraduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Kyuseok KimDepartment of Emergency Medicine, Bundang CHA Hospital, Seongnam-si, Gyeonggi-Do, 13496, Korea.
Doo Ryeon ChungDivision of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
In Young YooDepartment of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Hee Jae HuhDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
Hyun-Seok MinTomocube Inc., Daejeon, 34109, Republic of Korea.
Nam Yong LeeDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea. micro.lee@samsung.com.
YongKeun ParkDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea. yk.park@kaist.ac.kr.ORCID http://orcid.org/0000-0003-0528-6661

Funding

National Research Foundation of Korea (NRF) 2015R1A3A2066550National Research Foundation of Korea (NRF) 2017M3C1A3013923National Research Foundation of Korea (NRF) 2018K000396
6 · The paper itself

Abstract

The healthcare industry is in dire need of rapid microbial identification techniques for treating microbial infections. Microbial infections are a major healthcare issue worldwide, as these widespread diseases often develop into deadly symptoms. While studies have shown that an early appropriate antibiotic treatment significantly reduces the mortality of an infection, this effective treatment is difficult to practice. The main obstacle to early appropriate antibiotic treatments is the long turnaround time of the routine microbial identification, which includes time-consuming sample growth. Here, we propose a microscopy-based framework that identifies the pathogen from single to few cells. Our framework obtains and exploits the morphology of the limited sample by incorporating three-dimensional quantitative phase imaging and an artificial neural network. We demonstrate the identification of 19 bacterial species that cause bloodstream infections, achieving an accuracy of 82.5% from an individual bacterial cell or cluster. This performance, comparable to that of the gold standard mass spectroscopy under a sufficient amount of sample, underpins the effectiveness of our framework in clinical applications. Furthermore, our accuracy increases with multiple measurements, reaching 99.9% with seven different measurements of cells or clusters. We believe that our framework can serve as a beneficial advisory tool for clinicians during the initial treatment of infections.

Identifiers

PMID35739098
PMCPMC9226356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.